Is it safe?
Can AXSM take a bad year?
Axsome Therapeutics, Inc. holds $132M more cash than debt, and is burning $18M a quarter, about 4.5 years of cover.
$132M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 10.03
Altman Z-score · safe zone, above 3
- Cash runway
- 4.5 years
Cash runway · burning $18M a quarter at the current rate
Details›
- Total debtQ2 2026
- $188M
- Cash and short-term investments
- $320M
- Net cash
- $132M
- EBITDA, trailing twelve months
- −$183M
- Operating profit, trailing twelve months
- −$186M
- Debt / equity
- 2.26×
- Annualised volatilitytwo years of daily moves
- 44%
- Worst drawdown on file
- −81%
- Below its 52-week high
- −19%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.